Clinical Trials Browser

Leiomyosarcoma × Dacarbazine × Clear all

NCT03016819 2026-02-25

APROMISS

Phase 3 Recruiting

Leiomyosarcoma, Sarcoma, Sarcoma, Synovial, Sarcoma, Alveolar Soft Part

NCT05269355 2025-06-13

SUNRISELMS

Phase 2/3 Terminated

359 enrolled 15 charts

Leiomyosarcoma

NCT04535271 2025-02-24

TAGGED

Phase 2 Recruiting

Leiomyosarcoma

NCT03277924 2024-08-13

ImmunoSarc

Phase 1/2 Completed

Chondrosarcoma, Extraskeletal Myxoid, Bone Neoplasms, Chondrosarcoma, Hemangioendothelioma, Hemangiosarcoma, Leiomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Sarcoma, Synovial, Sarcoma, Clear Cell, Sarcoma, Alveolar Soft Part, Hemangioendothelioma, Epithelioid, Histiocytoma, Malignant Fibrous, Solitary Fibrous Tumors

NCT03761095 2024-03-15

A Study of Unesbulin (PTC596) in Combination With Dacarbazine in Participants With Advanced Leiomyosarcoma (LMS)

Phase 1 Completed

Leiomyosarcoma

NCT01692678 2018-07-11

A Study of Trabectedin (YONDELIS) in Patients With Locally Advanced or Metastatic Liposarcoma or Leiomyosarcoma

Phase 3 Completed

Leiomyosarcoma, Liposarcoma, Sarcoma

NCT01343277 2016-08-26

A Study of Trabectedin or Dacarbazine for the Treatment of Patients With Advanced Liposarcoma or Leiomyosarcoma

Phase 3 Completed

579 enrolled 13 charts

Leiomyosarcoma

NCT00837148 2015-11-20

Sorafenib and Dacarbazine in Soft Tissue Sarcoma

Phase 2 Completed

37 enrolled 6 charts

Leiomyosarcoma, Sarcoma, Sarcoma, Synovial, Neurofibrosarcoma